Catalyst Wire Dossier Catalyst Wire Dossier

Valsartan/Levamlodipine (SYH9056) Tablets

Valsartan/Levamlodipine · CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Valsartan/Levamlodipine (SYH9056) Tablets, covering 2025-01-13 to 2025-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients [Phase 3]

See pricing